End Stage Renal Disease Clinical Trials in Dallas, Texas
4 studies are recruiting for end stage renal disease in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
A prospective, single-arm, multi-center post-market surveillance study of the BD® WavelinQ™ EndoAVF System for the Creation of Arteriovenous (AV) Fistula in Patients Requiring Dialysis.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Texas Southwestern Medical Center, Dallas, Texas
- Locations
- 17 in total
- Run by
- C. R. Bard
-
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
Kidney failure has been recognized as one of the most costly chronic conditions among United States Veterans. Approximately 13,000 Veterans develop kidney failure each year, and most require hemodialysis initiation. Hemodialysis patients suffer significantly increased risk of death and hospitalizat…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas
- Run by
- VA Office of Research and Development
-
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
The goal of this observational study is to increase the understanding of the safety and performance of Merit Medical's HeRO Graft System (HeRO) and Super HeRO Adaptor and Support Seal System (Super HeRO) devices. This study includes adults that are being treated with one of these devices as part of…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Baylor Scott & White Heart and Vascular Hospital - Dallas, Dallas, Texas
- Locations
- 7 in total
- Run by
- Merit Medical Systems, Inc.
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
This is a prospective, multi-center, two-arm, randomized trial to quantify the performance of the EchoMark®/EchoSure® System for AVF diagnostic ultrasound when used under a protocol of biweekly use for assessing fistula maturation and reducing time to Clinical Maturation.
- Stage
- Not phased
- Ages
- 18 to 84
- Site
- Baylor Scott & White Heart and Vascular Hospital, Dallas, Texas
- Locations
- 21 in total
- Run by
- Sonavex, Inc.
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.